These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30560088)

  • 1. Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Ji J; Rong Y; Luo CL; Li S; Jiang X; Weng H; Chen H; Zhang WW; Xie W; Wang FB
    Front Oncol; 2018; 8():569. PubMed ID: 30560088
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A miRNA Combination as Promising Biomarker for Hepatocellular Carcinoma Diagnosis: A Study Based on Bioinformatics Analysis.
    Ji J; Chen H; Liu XP; Wang YH; Luo CL; Zhang WW; Xie W; Wang FB
    J Cancer; 2018; 9(19):3435-3446. PubMed ID: 30310500
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
    Song SK; Jung WY; Park SK; Chung CW; Park Y
    PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate miRNAs and pathogenesis investigation for hepatocellular carcinoma based on bioinformatics analysis.
    Ding W; Yang H; Gong S; Shi W; Xiao J; Gu J; Wang Y; He B
    Oncol Lett; 2017 May; 13(5):3409-3414. PubMed ID: 28521446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
    Chen Q; Qiu XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):522-527. PubMed ID: 28468075
    [No Abstract]   [Full Text] [Related]  

  • 8. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    Zhang J; Chong CC; Chen GG; Lai PB
    PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
    Nagy Á; Lánczky A; Menyhárt O; Győrffy B
    Sci Rep; 2018 Jun; 8(1):9227. PubMed ID: 29907753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis.
    Shi Y; Men J; Sun H; Tan J
    Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
    Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 15. A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
    Liu G; Wang H; Fu JD; Liu JY; Yan AG; Guan YY
    APMIS; 2017 Jul; 125(7):614-622. PubMed ID: 28430373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.
    Huang C; Tang S; Shen D; Li X; Liang L; Ding Y; Xu B
    Oncol Lett; 2021 Feb; 21(2):168. PubMed ID: 33552286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma.
    Ma X; Zhou L; Zheng S
    PeerJ; 2020; 8():e8930. PubMed ID: 32296612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.